Downregulation of miR-575 Inhibits the Tumorigenesis of Gallbladder Cancer via Targeting p27 Kip1

References

• Zhong Y, Wu X, Li Q, et al. Long noncoding RNAs as potential biomarkers and therapeutic targets in gallbladder cancer: a systematic review and meta-analysis. Cancer Cell Int. 2019;19:169. doi:10.1186/s12935-019-0891-131297033
   PubMed Web of Science ®Google Scholar
• Wang JW, Peng SY, Li JT, et al. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Lett. 2009;281(1):71–81. doi:10.1016/j.canlet.2009.02.02019299076
   PubMed Web of Science ®Google Scholar
• Hoyos S, Navas MC, Restrepo JC, Botero RC. Current controversies in cholangiocarcinoma. Biochim Biophys Acta Mol Basis Dis. 2018;1864(4 Pt B):1461–1467. doi:10.1016/j.bbadis.2017.07.02728756216
   PubMed Web of Science ®Google Scholar
• Liu TY, Tan ZJ, Jiang L, et al. Curcumin induces apoptosis in gallbladder carcinoma cell line GBC-SD cells. Cancer Cell Int. 2013;13(1):64. doi:10.1186/1475-2867-13-6423802572
   PubMedGoogle Scholar
• Pu M, Chen J, Tao Z, et al. Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional regulation of gene expression. Cell Mol Life Sci. 2019;76(3):441–451. doi:10.1007/s00018-018-2940-730374521
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203–222. doi:10.1038/nrd.2016.24628209991
   PubMed Web of Science ®Google Scholar
• Yao Y, Suo AL, Li ZF, et al. MicroRNA profiling of human gastric cancer. Mol Med Rep. 2009;2(6):963–970. doi:10.3892/mmr_0000019921475928
   PubMed Web of Science ®Google Scholar
• Zhang X, Xin G, Sun D. Serum exosomal miR-328, miR-575, miR-134 and miR-671-5p as potential biomarkers for the diagnosis of Kawasaki disease and the prediction of therapeutic outcomes of intravenous immunoglobulin therapy. Exp Ther Med. 2018;16(3):2420–2432. doi:10.3892/etm.2018.645830186482
   PubMed Web of Science ®Google Scholar
• Wang H, Yan C, Shi X, et al. MicroRNA-575 targets BLID to promote growth and invasion of non-small cell lung cancer cells. FEBS Lett. 2015;589(7):805–811. doi:10.1016/j.febslet.2015.02.01325728273
   PubMed Web of Science ®Google Scholar
• Roskoski R Jr. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs. Pharmacol Res. 2019;139:471–488. doi:10.1016/j.phrs.2018.11.03530508677
   PubMed Web of Science ®Google Scholar
• Barbacid M, Ortega S, Sotillo R, et al. Cell cycle and cancer: genetic analysis of the role of cyclin-dependent kinases. Cold Spring Harb Symp Quant Biol. 2005;70:233–240. doi:10.1101/sqb.2005.70.00516869759
   PubMedGoogle Scholar
• Denicourt C, Dowdy SF. Cip/Kip proteins: more than just CDKs inhibitors. Genes Dev. 2004;18(8):851–855. doi:10.1101/gad.120530415107401
   PubMed Web of Science ®Google Scholar
• Jasinski S, Perennes C, Bergounioux C, Glab N. Comparative molecular and functional analyses of the tobacco cyclin-dependent kinase inhibitor NtKIS1a and its spliced variant NtKIS1b. Plant Physiol. 2002;130(4):1871–1882. doi:10.1104/pp.00857312481070
   PubMed Web of Science ®Google Scholar
• Zhou N, Huang Q, Cheng W, et al. p27kip1 haploinsufficiency preserves myocardial function in the early stages of myocardial infarction via Atg5mediated autophagy flux restoration. Mol Med Rep. 2019;20(4):3840–3848. doi:10.3892/mmr.2019.1063231485654
   PubMed Web of Science ®Google Scholar
• Filipits M, Puhalla H, Wrba F. Low p27Kip1 expression is an independent prognostic factor in gallbladder carcinoma. Anticancer Res. 2003;23(1B):675–679.12680166
   PubMed Web of Science ®Google Scholar
• Rippa E, La Monica G, Allocca R, et al. Overexpression of gastrokine 1 in gastric cancer cells induces Fas-mediated apoptosis. J Cell Physiol. 2011;226(10):2571–2578. doi:10.1002/jcp.2260121792914
   PubMed Web of Science ®Google Scholar
• Menbari MN, Rahimi K, Ahmadi A, et al. miR-483-3p suppresses the proliferation and progression of human triple negative breast cancer cells by targeting the HDAC8 oncogene. J Cell Physiol. 2019.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang L, Chen M, Liu D. miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression. Artif Cells Nanomed Biotechnol. 2020;48(1):315–324. doi:10.1080/21691401.2019.170372431858815
   PubMed Web of Science ®Google Scholar
• Zhou T, Yu L, Huang J, et al. GDF10 inhibits proliferation and epithelial-mesenchymal transition in triple-negative breast cancer via upregulation of Smad7. Aging (Albany NY). 2019;11(10):3298–3314. doi:10.18632/aging.10198331147529
   PubMedGoogle Scholar
• Wu XS, Wang F, Li HF, et al. LncRNA-PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis. EMBO Rep. 2017;18(10):1837–1853. doi:10.15252/embr.20174414728887321
   PubMed Web of Science ®Google Scholar
• Chandra V, Kim JJ, Mittal B, Rai R. MicroRNA aberrations: an emerging field for gallbladder cancer management. World J Gastroenterol. 2016;22(5):1787–1799. doi:10.3748/wjg.v22.i5.178726855538
   PubMed Web of Science ®Google Scholar
• Ma Q, Zhang Y, Liang H, et al. EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway. Cancer Lett. 2018;430:97–108. doi:10.1016/j.canlet.2018.05.02229778567
   PubMed Web of Science ®Google Scholar
• Wang YN, Xu F, Zhang P, et al. MicroRNA-575 regulates development of gastric cancer by targeting PTEN. Biomed Pharmacother. 2019;113:108716. doi:10.1016/j.biopha.2019.10871630844657
   PubMed Web of Science ®Google Scholar
• Yan S, Tang Z, Chen K, et al. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression. J Exp Clin Cancer Res. 2018;37(1):214. doi:10.1186/s13046-018-0853-930176933
   PubMedGoogle Scholar
• Backes C, Meese E, Keller A. Specific miRNA disease biomarkers in blood, serum and plasma: challenges and prospects. Mol Diagn Ther. 2016;20(6):509–518. doi:10.1007/s40291-016-0221-427378479
   PubMed Web of Science ®Google Scholar
• Bernardo BC, Ooi JY, Lin RC, McMullen JR. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart. Future Med Chem. 2015;7(13):1771–1792. doi:10.4155/fmc.15.10726399457
   PubMed Web of Science ®Google Scholar
• Bencivenga D, Caldarelli I, Stampone E, et al. p27(Kip1) and human cancers: A reappraisal of a still enigmatic protein. Cancer Lett. 2017;403:354–365. doi:10.1016/j.canlet.2017.06.03128687353
   PubMed Web of Science ®Google Scholar
• Huang SH, Tseng JC, Lin CY, et al. Rooibos suppresses proliferation of castration-resistant prostate cancer cells via inhibition of Akt signaling. Phytomedicine. 2019;64:153068. doi:10.1016/j.phymed.2019.15306831419729
   PubMed Web of Science ®Google Scholar
• An HJ, Ryu M, Jeong HJ, et al. Higd-1a regulates the proliferation of pancreatic cancer cells through a pERK/p27(KIP1)/pRB pathway. Cancer Lett. 2019;461:78–89. doi:10.1016/j.canlet.2019.07.00731310799
   PubMed Web of Science ®Google Scholar
• Bo L, Wei B, Wang Z, et al. Bioinformatics analysis of the CDK2 functions in neuroblastoma. Mol Med Rep. 2018;17(3):3951–3959. doi:10.3892/mmr.2017.836829328425
   PubMed Web of Science ®Google Scholar
• Ji X, Humenik J, Yang D, Liebhaber SA. PolyC-binding proteins enhance expression of the CDK2 cell cycle regulatory protein via alternative splicing. Nucleic Acids Res. 2018;46(4):2030–2044. doi:10.1093/nar/gkx125529253178
   PubMed Web of Science ®Google Scholar
• Pellerano M, Tcherniuk S, Perals C, et al. Targeting conformational activation of CDK2 kinase. Biotechnol J. 2017;12(8). doi:10.1002/biot.201600531.
   PubMed Web of Science ®Google Scholar
• Karst AM, Jones PM, Vena N, et al. Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers. Cancer Res. 2014;74(4):1141–1152. doi:10.1158/0008-5472.CAN-13-224724366882
   PubMed Web of Science ®Google Scholar
• Liu JL, Ma HP, Lu XL, et al. NF-kappaB induces abnormal centrosome amplification by upregulation of CDK2 in laryngeal squamous cell cancer. Int J Oncol. 2011;39(4):915–924. doi:10.3892/ijo.2011.112521769424
   PubMed Web of Science ®Google Scholar
• Su C, Sun Q, Liu S, et al. Targeting p38gamma to inhibit human colorectal cancer cell progression. Biochem Biophys Res Commun. 2019;517(1):172–179. doi:10.1016/j.bbrc.2019.07.03831349971
   PubMed Web of Science ®Google Scholar
• Huang M, Zhong Y, Lin L, et al. 1,2-Dichloroethane induces cerebellum granular cell apoptosis via mitochondrial pathway in vitro and in vivo. Toxicol Lett. 2020;322:87–97. doi:10.1016/j.toxlet.2020.01.00431935479
   PubMed Web of Science ®Google Scholar
• Liu Y, Bi T, Shen G, et al. Lupeol induces apoptosis and inhibits invasion in gallbladder carcinoma GBC-SD cells by suppression of EGFR/MMP-9 signaling pathway. Cytotechnology. 2016;68(1):123–133. doi:10.1007/s10616-014-9763-725037728
   PubMed Web of Science ®Google Scholar